Knee Osteoarthritis and Rehabilitation
Knee Osteoarthritis and Lazer Therapy
Karabuk University
30 participants
Jul 1, 2023
INTERVENTIONAL
Conditions
Summary
Osteoarthritis (OA) is a chronic degenerative disease of articular cartilage that causes hypertrophic changes in bone. OA is a non-inflammatory progressive musculoskeletal disease and is one of the most common degenerative diseases in the general population. OA is characterized by progressive cartilage destruction in load-bearing joints, subchondral sclerosis, osteophyte formation, and some biochemical and morphological changes in the synovial membrane and joint capsule. Common symptoms of knee osteoarthritis are; Knee pain that increases with activity, limitation of normal joint movement of the knee, edema, and knee pain that begins with prolonged sitting. The aim of this study is to evaluate the effects of laser treatment applied in addition to conventional physiotherapy on pain, function, muscle strength and balance in patients with knee osteoarthritis who received PRP.
Eligibility
Inclusion Criteria6
- Volunteering to participate in the study
- Being diagnosed with knee OA by a specialist physician
- Having had PRP injection applied by a specialist physician
- Having unilateral knee OA
- Being stage I-stage III in the Kellgren-Lawrence OA classification
- Being between the ages of 18-65
Exclusion Criteria4
- Being stage IV in the Kellgren-Lawrence OA classification
- BMI being more than 40 kg/m2
- Patients who do not cooperate well
- Patients with neurological or neuromuscular disease
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
In the study group, low-dose laser treatment was applied in addition to conventional treatment. Chattanoga Group Therapeutic Laser device was used for laser treatment. Laser treatment was applied to 8 sensitive points around the knee for 1 minute, for a total of 8 minutes. Laser treatment was applied continuously, with a wavelength of 830nm and a power of 6J.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06432842